European venous disease registry for lower limbs
Official title: European Venous Registry
Run by IRCCS San Raffaele · NCT06906250 · Data updated 2026-11-12
This project collects health and treatment information over ten years to see which treatments and outcomes occur in adults with new imaging-confirmed deep venous disease of the lower limbs, including the iliac, common femoral veins, or the inferior vena cava.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 10 sites (Marseille, France and 9 other locations) |
| Status | Recruiting |
| Started | July 5, 2025 |
| Main results expected | September 30, 2034 |
| Study ends | September 30, 2034 |
| Registry record updated | September 8, 2025 |
| Trial ID | NCT06906250 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with a new imaging-confirmed diagnosis of acute or chronic lower limb deep venous disease involving the iliac and/or common femoral veins, with or without extension to the inferior vena cava, who can give consent.
✕Probably not a fit
People under 18, those unable to consent, and patients with isolated upper limb DVT, isolated deep vein thrombosis below the common femoral vein, isolated superficial venous disease, central venous thrombosis, or isolated varicose veins are not included and therefore would not benefit from enrollment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The European Venous Registry is an international observational registry enrolling adults with a new imaging-confirmed diagnosis of acute or chronic deep venous disease affecting the iliac and/or common femoral veins or the inferior vena cava. Participating centers record diagnostic imaging, treatments (including interventions), follow-up outcomes, and patient-reported measures over a ten-year period. No experimental treatments are assigned by the registry; data are collected from routine clinical care. The goal is to compile long-term outcome data to inform clinical decision-making and guideline development.
Why it matters
Potential benefit: If successful, the registry could help doctors choose better treatments and improve outcomes for people with deep venous disease of the legs.
How similar studies have gone: Previous regional and national venous registries have successfully contributed outcome data and informed practice, so this approach builds on established observational methods rather than being entirely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with an imaging-confirmed new diagnosis of acute or chronic lower limb deep venous disease involving the iliac and/or common femoral veins, with or without extension to the inferior vena cava, or patients with an imaging-confirmed new diagnosis involving the IVC only. * Consent to enter registry. Exclusion Criteria: * Unable to consent to enter into registry. * Isolated upper limb DVT. * Central venous thrombosis (e.g. superior vena cava obstruction). * Isolated deep vein thrombosis below the common femoral vein. * Isolated superficial venous thrombosis. * Isolated superficial venous thrombophlebitis. * Isolated varicose veins. * Aged \<18 years.
Where it's running
-
Department of Vascular Surgery
Marseille, France, France Recruiting -
European Venous Center
Aachen, Germany, Germany Recruiting -
Clinic of Vascular and Endovascular Surgery at Athens Medical Group
Athens, Greece, Greece Recruiting -
Interventional Radiology, Galway University Hospitals
Galway, Ireland, Ireland Recruiting -
IRCCS San Raffaele Hospital
Milan, Italy, Italy Recruiting -
Department of Vascular and Endovascular Surgery, Erasmus Medical Centre
Rotterdam, Netherlands, Netherlands Recruiting
Show 4 more locations
-
Vascular and Endovascular Department, Viamed Hospitals
Madrid, Spain, Spain Recruiting -
Department of Cardiovascular Surgery, Acibadem University School of Medicine,
Istanbul, Turkey, Turkey (Türkiye) Recruiting -
North Bristol NHS Trust
Bristol, United Kingdom, United Kingdom Recruiting -
St Thomas' Hospital
London, United Kingdom, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
CAR-T Therapy Safety, Response, and Immune-Escape: Observational Study in Adults
This observational study looks at adults who receive CAR-T cell therapy or bispecific antibodies to see which factors predict response and immune-related side effects.
-
Photon-counting CT versus traditional CT for suspected coronary artery disease
This trial tests whether photon-counting CT can better diagnose obstructive CAD in people who need a coronary CTA than the standard energy-integrating detector CT.
-
Intensive 4-week postoperative multimodal rehab after proximal pancreatic surgery
This study tests whether a 4-week multimodal rehabilitation program can help adults who have severe complications after proximal pancreatic surgery recover better.
-
Engineered HMGB1 protein as a companion therapy for LAMA2-related muscular dystrophy
This study tests how existing patient samples from people with LAMA2-related muscular dystrophy can be used to explore a potential companion therapy using an engineered HMGB1 protein.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.